Regulatory Briefs: Guidance On Distributing Publications On Unapproved Uses; Export Certification Updates
This article was originally published in The Gray Sheet
Executive Summary
FDA issues a revised draft guidance on distributing scientific publications on unapproved new uses of medical products. The agency enhances its export certification and tracking system. More regulatory news.